- Home
- CABO vs MYGN Comparison
CABO vs MYGN Comparison
Compare CABO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- MYGN
- Stock Information
- Founded
- CABO 1980
- MYGN 1991
- Country
- CABO United States
- MYGN United States
- Employees
- CABO N/A
- MYGN N/A
- Industry
- CABO Cable & Other Pay Television Services
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CABO Telecommunications
- MYGN Health Care
- Exchange
- CABO Nasdaq
- MYGN Nasdaq
- Market Cap
- CABO 717.5M
- MYGN 744.7M
- IPO Year
- CABO N/A
- MYGN 1995
- Fundamental
- Price
- CABO $124.47
- MYGN $5.34
- Analyst Decision
- CABO Hold
- MYGN Hold
- Analyst Count
- CABO 3
- MYGN 15
- Target Price
- CABO $231.00
- MYGN $15.14
- AVG Volume (30 Days)
- CABO 215.6K
- MYGN 1.4M
- Earning Date
- CABO 07-31-2025
- MYGN 08-05-2025
- Dividend Yield
- CABO 7.10%
- MYGN N/A
- EPS Growth
- CABO N/A
- MYGN N/A
- EPS
- CABO N/A
- MYGN N/A
- Revenue
- CABO $1,555,831,000.00
- MYGN $831,300,000.00
- Revenue This Year
- CABO N/A
- MYGN N/A
- Revenue Next Year
- CABO N/A
- MYGN $6.68
- P/E Ratio
- CABO N/A
- MYGN N/A
- Revenue Growth
- CABO N/A
- MYGN 7.38
- 52 Week Low
- CABO $121.37
- MYGN $3.81
- 52 Week High
- CABO $437.00
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- CABO 36.92
- MYGN 50.85
- Support Level
- CABO $126.35
- MYGN $4.90
- Resistance Level
- CABO $137.88
- MYGN $5.83
- Average True Range (ATR)
- CABO 6.48
- MYGN 0.28
- MACD
- CABO 1.54
- MYGN 0.04
- Stochastic Oscillator
- CABO 11.85
- MYGN 54.21
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.